The LH endocrine profile in gonadotropin-releasing hormone analogue cycles

References

• Evers JL. Female subfertility. Lancet (London, England). 2002;360(9327):151–159.
   PubMed Web of Science ®Google Scholar
• Orvieto R. HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter? Reprod Biomed Online. 2019;39(6):1001–1006.
   PubMed Web of Science ®Google Scholar
• Kim HH, Speedy SE. The promised land of individualized ovarian stimulation: Are we there yet? Fertil Steril. 2021;115(4):893–894.
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993–999.
   PubMed Web of Science ®Google Scholar
• The Eshre Guideline Group On Ovarian Stimulation. ESHRE guideline: ovarian stimulation for IVF/ICSI(†). Hum Reprod Open. 2020;2020(2):hoaa009.
   PubMedGoogle Scholar
• Gianaroli L, Racowsky C, Geraedts J, et al. Best practices of ASRM and ESHRE: a journey through reproductive medicine. Hum Reprod. 2012;27(12):3365–3379.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Venetis CA, Fatemi HM, et al. Optimising follicular development, pituitary suppression, triggering and luteal phase support during assisted reproductive technology: a delphi consensus. [Original Research]. Front Endocrinol (Lausanne). 2021;12(446).
   Google Scholar
• Bosch E, Alviggi C, Lispi M, et al. Reduced FSH and LH action: implications for medically assisted reproduction. Hum Reprod. 2021;36(6):1469–1480.
   PubMed Web of Science ®Google Scholar
• Fritz MA, Speroff L. 2011. Clinical gynaecologic endocrinology and infertility. 8th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins.
   Google Scholar
• Lee SJ, Lenton EA, Sexton L, et al. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod. 1988;3(7):851–855. doi:10.1093/oxfordjournals.humrep.a136796.
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction (Oxford, England). 2000;15(5):1003–1008.
   PubMed Web of Science ®Google Scholar
• Macklon NS, Stouffer RL, Giudice LC, et al. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170–207.
   PubMed Web of Science ®Google Scholar
• Hayden C. GnRH analogues: applications in assisted reproductive techniques. Eur J Endocrinol. 2008;159(suppl_1):S17–S25.
   PubMedGoogle Scholar
• The ganirelix dose-finding study group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (puregon). Hum Reprod. 1998;13(11):3023–3031. PMID: 9853849.
   PubMed Web of Science ®Google Scholar
• The ganirelix dose-finding study group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (puregon). Hum Reprod. 1998;13(11):3023–3031. PMID: 9853849.
   PubMed Web of Science ®Google Scholar
• Anderson RE, Stein AL, Paulson RJ, et al. Effects of norethindrone on gonadotropin and ovarian steroid secretion when used for cycle programming during in vitro fertilization. Fertil Steril. 1990;54(1):96–101.
   PubMed Web of Science ®Google Scholar
• Tsai CC, Yen SS. The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function. J Clin Endocrinol Metab. 1971;33(6):917–923.
   PubMed Web of Science ®Google Scholar
• Rombauts L, Healy D, Norman RJ. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod. 2006;21(1):95–103.
   PubMed Web of Science ®Google Scholar
• Cédrin-Durnerin I, Bständig B, Parneix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22(1):109–116.
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Bermejo A, Ruiz F, et al. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial. Fertil Steril. 2011;96(3):590–593.
   PubMed Web of Science ®Google Scholar
• Casarini L, Riccetti L, Paradiso E, et al. Two human menopausal gonadotrophin (hMG) preparations display different early signaling in vitro. Mol Hum Reprod. 2020;26(12):894–905.
   PubMed Web of Science ®Google Scholar
• Benmachiche A, Benbouhedja S, Zoghmar A, et al. Low LH level on the day of GnRH agonist trigger Is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF/ICSI treatment and fresh embryo transfer. Front Endocrinol (Lausanne). 2019;10:639.
   PubMed Web of Science ®Google Scholar
• Lahoud R, Jefout MA, Tyler J, et al. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Hum Reprod. 2006;21(10):2645–2649.,
   PubMed Web of Science ®Google Scholar
• Kol S, Homburg R. Change, change, change: hormonal actions depend on changes in blood levels. Hum Reprod. 2008;23(5):1004–1006.
   PubMed Web of Science ®Google Scholar
• Alviggi C, Conforti A, Esteves SC, et al. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018;109(4):644–664.
   PubMed Web of Science ®Google Scholar
• Bosch E, Labarta E, Crespo J, et al. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011;95(3):1031–1036.
   PubMed Web of Science ®Google Scholar